The strong HPV dependent activity of roscovitine cannot be attributed to the inhibition of CDK1/2, since the sensitivity of head and neck cancer cells to selective CDK1/2 inhibitor was not dependent on HPV status (Figure 8). Here, CDK1 is linked to head and neck cancer.